TCGX Acquisition Corp. closes $86.25 million IPO; $86.25 million placed in trust
TCGX Acquisition Corp., a special purpose acquisition company focused on healthcare, closed its initial public offering on August 6, 2026, selling 8,625,000 Class A ordinary shares at $10.00 each for gross proceeds of $86.25 million. The filing says $86.25 million was placed in a trust account, which will not be released except for a business combination, certain shareholder redemptions, or interest used for taxes, and the company has 24 months from the IPO closing to complete a business combination. Three independent directors were appointed and two directors resigned.
Key points
- Sold 8,625,000 Class A ordinary shares at $10.00 per share, including 1,125,000 shares from the full exercise of the underwriters' over-allotment option, for gross proceeds of $86.25 million.
- Concurrent private placement of 522,500 shares at $10.00 per share, or $5.225 million, to the sponsor (436,250 shares) and Jefferies LLC (86,250 shares).
- $86.25 million placed in a trust account at Citibank, N.A., with a 24-month deadline from the IPO closing to complete an initial business combination.
- Andrew Cheng, Ying Huang and Wei Lin appointed to the board on August 4, 2026; Chen Yu and Craig Skaling resigned from the board.
The filing
Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.